Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Geraldine Henwood currently holds 2,427 shares of MAP Pharmaceuticals, Inc. (MAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Geraldine Henwood has been a net seller of MAPP stock. They have purchased $59.4K and sold $7.5M worth of shares.
Geraldine Henwood's most recent insider trade was on Dec 15, 2022, when they purchased 1,200 shares at $2.55 per share.
Geraldine Henwood serves as Executive at MAP Pharmaceuticals, Inc. (MAPP). They have executed 82 insider transactions totaling $7.5M over their tenure at the company.
Geraldine Henwood holds the position of Executive at MAP Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Geraldine Henwood has shown a selling trading pattern, with $59.4K in total purchases and $7.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Geraldine Henwood was on Jan 15, 2014, when they sold $1.8M worth of ALKS shares. This transaction involved 37,600 shares at $47.52 per share.
Geraldine Henwood currently owns 2,427 shares of MAP Pharmaceuticals, Inc. (MAPP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Geraldine Henwood's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Geraldine Henwood has 82 Form 4 filings on record as an insider at MAP Pharmaceuticals, Inc..
Set alerts for Geraldine Henwood and 40,000+ other insiders.